| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3467911 | European Journal of Internal Medicine | 2011 | 5 Pages |
Abstract
In our study of patients on hemodialysis with chronic hepatitis C, the use of peginterferon or a combination of peginterferon with a low daily dose of ribavirin achieved a high rate of SVR and the rate of dropout was low after pursuing an aggressive management of side effects.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
A. Giguere, A. Anas, T. Nasser, M.H. Hassan, U. Ahmed, N. Beejay, M. Nouh, M. Khalowf, A. Saleh, A. Khan, M. Attia, G. El-Azab,